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Integration of NPY, AGRP, and Melanocortin Signals
in the Hypothalamic Paraventricular Nucleus:
Evidence of a Cellular Basis for the Adipostat
Microinjection of NPY into the paraventricular nucleus
of the hypothalamus (PVH) stimulates feeding (Stanley,
1993); alters body temperature and regulates peripheral
energy metabolism (Billington et al., 1991); increases
plasma insulin levels (Tomaszuk et al., 1996); and de-
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creases sympathetic nerve activity in brown adiposePortland, Oregon 97201
tissue (Egawa et al., 1991).²Department of Pharmacology
Melanocortin peptides have been demonstrated toUniversity of Alberta
inhibit energy intake (Fan et al., 1997), and recent dataEdmonton T6G 2H7
suggest that they may play a role in energy expenditureCanada
as well (Haynes et al., 1999). Genetic alterations affect-
ing the central melanocortin system have been demon-
strated to disrupt energy homeostasis, causing obesitySummary
in mice ectopically expressing agouti (Bultman et al.,
1992) or the hypothalamic agouti-related protein (AGRP),Energy stores are held relatively constant in many
an endogenous antagonist of the melanocortin-4 recep-mammals. The circuitry necessary for maintaining en-
tor (MC4-R) (Graham et al., 1997; Ollmann et al., 1997)ergy homeostasis should (1) sense the amount of en-
and MC4-R knockout (MC4-RKO) mice (Huszar et al.,ergy stored in adipose tissue, (2) sense and integrate
1997). An obesity syndrome has also been characterizedthe multiple opposing signals regarding nutritional
in families with rare deleterious mutations in the proopio-state, and (3) provide output regulating energy intake
melanocortin (POMC) gene, the prohormone precursorand expenditure to maintain energy homeostasis. We
of the melanocortin peptides (Krude et al., 1998), anddemonstrate that individual neurons within the para-
heterozygous mutations in the MC4-R have been re-ventricular nucleus of the hypothalamus (PVH) are ca-
ported to be associated with common pediatric obesitypable of detection and integration of orexigenic (neu-
(Vaisse et al., 1998; Yeo et al., 1998). These data suggestropeptide Y [NPY]) and anorexigenic (melanocortin)
that the central melanocortin system, defined here assignals, that NPY and melanocortins are functional
arcuate nucleus neurons expressing the melanocortinantagonists of each other within the PVH in the regula-
agonist a-melanocyte-stimulating hormone (a-MSH) ortion of feeding behavior, and that melanocortin admin-
the melanocortin antagonist AGRP, and the melanocor-istration within the PVH regulates both feeding behav-
tin receptor±expressing targets of these neurons mayior and energy expenditure. These data provide a
be involved in the regulation of energy homeostasis incellular basis for the adipostat within neurons in the
mice and humans.PVH that appear to be jointly regulated by NPY- and
Centrally administered melanocortin antagonists stimu-melanocortin-responsive neurons.
late food intake (Fan et al., 1997), implying that endoge-
nous melanocortin agonists, released by arcuate nu-Introduction
cleus POMC neurons, act to tonically inhibit energy
intake. The discovery of the hypothalamic melanocor-The concept of the lipostat or adipostat was originally
tin antagonist AGRP (Shutter et al., 1997) suggests,
proposed as a model for the regulation of food intake
however, that the melanocortin system may also sense
and posited that the amount of energy stored in the
orexigenic signals. AGRP has been demonstrated to
form of adipose tissue could be detected and held con- be a specific high-affinity competitive antagonist of the
stant by the CNS (Kennedy, 1953). The data in support MC3-R and MC4-R (Fong et al., 1997), and intracerebro-
of the adipostat from both rodents and humans are ventricular administration of AGRP alone potently stimu-
extensive. In rats, for example, following caloric restric- lates feeding (Rossi et al., 1998). Furthermore, AGRP
tion and a weight loss of 10%±15%, animals increase and NPY are largely coexpressed in the same set of
food intake and decrease energy expenditure until they arcuate neurons (Broberger et al., 1998), and these neu-
return to their previous weight (Mitchel and Keesey, rons are shown to project to many of the same hypotha-
1977). Likewise, rats that have been rapidly increased lamic sites to which the arcuate nucleus POMC neurons
in weight also return to their previous weights after a project (Broberger et al., 1998; Haskell-Luevano et al.,
period of ad libitum feeding (Steffens, 1975). 1999). Finally, both the arcuate POMC and NPY/AGRP
A significant body of literature argues that the arcuate neurons are prominent sites of leptin receptor expres-
nucleus neuropeptide Y (NPY) neurons are involved in sion (HaÈ kansson et al., 1996; Cheung et al., 1997) and
energy homeostasis (for review, see Kalra et al., 1999). thus are capable of sensing energy stores as reflected
in serum leptin concentrations.
These data suggest that the arcuate NPY and melano-
cortin projections may be largely convergent, and we³ To whom correspondence should be addressed (e-mail: cone@
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Figure 1. NPY/AGRP, POMC, and MC4-R Fibers Are All Found within the mpPVH
(a) AGRP (green) and NPY (red) are coexpressed (yellow) in the same arcuate PVH projections in the rat.
(b) NPY- (red) and a-MSH- (green) containing fibers both appear in the mpPVH in the rat, but the peptides are not colocalized within the same
fibers (yellow).
(c) Expression of the MC4-R (red) within the mpPVH of the mouse.
(d) Absence of MC4-R IR in PVH of the MC4-RKO mouse demonstrates the specificity of the antibody. Experiments in (c) and (d) were
performed in the mouse to take advantage of the knockout control; comparable MC4-R IR was seen in the rat (data not shown). Nuclei are
seen in blue.
and orexigenic information derived from these inputs. Results
To identify a neuroanatomical substrate for the integra-
tion of the NPY and melanocortin signals, we first exam- AGRP/NPY-, POMC-, and MC4-R-Containing
ined the PVH, since both POMC and NPY/AGRP neurons Fibers Converge on the Medial Parvocellular
send dense projections to this brain region, and the PVH Paraventricular Nucleus of the Hypothalamus
is a potent site of NPY (Stanley, 1993) and melanocortin The colocalization of NPY and AGRP immunoreactivity
(Giraudo et al., 1998) action in the stimulation of feeding (IR) within the same neuronal processes in the medial
parvocellular paraventricular nucleus of the hypothala-behavior.
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mus (mpPVH) was demonstrated in the rat and mouse
by confocal microscopic analysis using double label
immunohistochemistry. Colocalization of AGRP IR (green)
with NPY IR (red) in the mpPVH could be clearly visual-
ized as a pattern of yellow fibrous staining (Figure 1a;
rat). Noncolocalized NPY IR (red) and AGRP IR (green)
could also be seen. Fibers showing IR for NPY alone
were expected, since AGRP is only made by arcuate
nucleus neurons, and z50% of the NPY released in the
PVH derives from nonarcuate NPY neurons (Sawchenko
et al., 1985). Since arcuate neurons containing AGRP
mRNA also were invariably found to express NPY mRNA
(Broberger et al., 1998), fibers in the PVH staining with
AGRP alone could represent a differential distribution
of the two peptides from the same NPY/AGRP arcuate
neurons.
Neurons containing the melanocortin peptide a-MSH
are also known to converge on this hypothalamic region
(Watson et al., 1978; Nilaver et al., 1979), and Figure 1b
shows these fibers (green) in the vicinity of punctate
NPY fibers (red) throughout the rat PVH. No significant
colocalization of NPY and a-MSH within the same neu-
rons was detected (yellow). Finally, MC4-R IR (red) is
also seen in the mpPVH (Figure 1c; mouse), and the
specificity of the staining achieved with this antibody is
demonstrated by the absence of any significant IR in
a comparable section prepared from the MC4-RKO
mouse (Figure 1d). The MC4-R appears to be primarily
on the terminals of axons in this section of the PVH,
suggesting that one mechanism of MC4-R action may
be presynaptic. Some MC4-R IR was also detected
within cell bodies (data not shown), consistent with the
observation of a limited amount of MC4-R mRNA ex-
pressed in PVH neurons themselves (Mountjoy et al.,
1994). MC4-R mRNA is found expressed at low levels
in a large number of both hypothalamic and extrahypo-
thalamic sites (Mountjoy et al., 1994). While the PVH
was one of the weaker sites of MC4-R mRNA expression,
it was one of the highest sites of MC4-R IR seen in
this study, suggesting that widely distributed MC4-R
mRNA±positive cells may send MC4-R-positive projec-
tions to the PVH. Similar NPY, AGRP, a-MSH, and MC4-R
IR patterns were observed in both rats and mice. Three- Figure 2. Intra-PVH Administration of Melanocortins Blocks Intra-
PVH Effects of NPY on Feeding Behavior and Stimulates Energydimensional reconstructions of four of these confocal
Expenditureimages are available for viewing (http://www.neuron.
(a) Microinjection of MTII (0.6 nmol/0.4 ml) into one side of PVH inorg/cgi/content/full/24/1/155/DC1).
male rats produces a specific and potent inhibition of nocturnal
feeding that was blocked by preadministration of antagonist
MTII and NPY Are Functional Antagonists SHU9119 (0.6 nmol/0.4 ml) (p , 0.0001, ACSF versus MTII; p , 0.01,
SHU9119±MTII versus ACSF±MTII). PVH administration of SHU9119in the PVH
(0.6 nmol/0.4 ml) significantly stimulated feeding (p , 0.01,Unilateral stereotaxic microinjection of MTII (0.6 nmol/
SHU9119±ACSF versus ACSF±ACSF).0.4 ml), a potent agonist of the central MC3 and MC4
(b) Microinjection of MTII (0.3 nmol/0.2 ml) into one side of the PVHreceptors (Hruby et al., 1995), into the PVH in rats pro-
produced a potent inhibition of feeding in fasted (16 hr) lean female
duced a potent inhibition of feeding lasting 12 hr, with control (ob/1 and 1/1) mice (p , 0.0001, ACSF versus MTII).
the normal rate resuming after about 14 hr (Figure 2a; (c) Coadministration of MTII (0.3 nM) and NPY (0.14 nmol) within the
PVH blocks the orexigenic activity of NPY (triple asterisks, p ,n 5 5, p , 0.0001). Preinjection of the same dose of a
0.0001, and double asterisks, p , 0.001 [NPY versus ACSF]; tripleMC3/MC4 receptor antagonist, SHU9119 (Hruby et al.,
pound signs, p , 0.001, and double pound signs, p , 0.01 [NPY1995) (0.6 nmol/0.4 ml), into the PVH 10±15 min before
versus MTII±NPY]).injection of MTII blocked the inhibitory effect of MTII on
(d) A single microinjection of MTII (0.45 nmol/0.3 ml) into one side of
feeding (n 5 5, p , 0.01). Administration of SHU9119 the PVH significantly increases oxygen consumption in lean (ob/1,
alone (0.6 nmol/0.4 ml) into the PVH significantly stimu- 1/1) mice (p , 0.0001, n 5 8).
lated feeding during the nocturnal period (n 5 5, p ,
0.01). Similarly, in lean female (ob/1 and 1/1) control
mice fasted for 16 hr, microinjection of MTII (0.3 nmol/
0.2 ml) into one side of the PVH resulted in a potent
Neuron
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Figure 3. Melanocortins and NPY Have Op-
posing Effects on GABA-Mediated Synaptic
Potentials Evoked in mpPVH Neurons
(a) Representative trace showing increase in
IPSC amplitude by MTII.
(b) Dose±response curve for the increase of
IPSC amplitude by MTII.
(c) Representative trace showing decrease in
IPSC amplitude by NPY.
(d) Time course of the normalized mean IPSC
response to MTII (n 5 8±14) or NPY (n 5 10±
13). Asterisk, p , 0.0002; and double dagger,
p , 0.0001.
(e) Effect of NPY and melanocortin com-
pounds on normalized peak IPSC amplitude
(percent change). Data indicate mean peak
IPSC values for each treatment (number of
independent cells in each treatment group,
left to right: 11, 24, 10, 9, 9, 6, 5, 3, 5, and
5). Antagonist effects (SHU9119, AGRP) were
determined by adding agonist after antago-
nist pretreatment. Significance relative to
ACSF control (asterisk, double dagger, x) or
respective agonist treatment (plus sign, dag-
ger): asterisk, p , 0.0002; double dagger, p ,
0.0001; x, p , 0.001; plus sign, p , 0.0001;
and dagger, p , 0.0001.
(f) Representative trace showing stimulation
of the amplitude of an IPSC by addition of
500 mM 8(4-Chlorophenylthio)-cAMP (CPT-
cAMP).
inhibitory effect on food intake for up to 4 hr in compari- The ability of intra-PVH melanocortin administration
to regulate energy expenditure was also examined byson with artificial cerebrospinal fluid± (ACSF-) treated
animals (Figure 2b; n 5 8, p , 0.0001). These data dem- assaying oxygen consumption in resting mice. Within 1
hr of treatment, the oxygen consumption in MTII-treatedonstrate that the full effect of melanocortin peptides on
feeding behavior, previously evoked by injection into the lean control mice (ob/1 and 1/1) was 4378 ml/kg/hr,
z170% higher than that observed in ACSF-treated micelateral ventricle, can be as potently elicited by specific
administration within a single hypothalamic nucleus, the (Figure 2d; 2534 ml/kg/hr, p , 0.0001). The extent of
increased oxygen consumption induced by MTII treat-PVH. Furthermore, the ability of the antagonist SHU9119
to stimulate feeding suggests a role for endogenous ment diminished gradually with time but was still signifi-
cantly higher than the control at the end of the testa-MSH release at the PVH in the tonic control of food
intake. period.
After demonstrating the potent effect of melanocortin
agonists and antagonists administered unilaterally in the MTII and NPY Have Opposing Actions
on GABA-Evoked Currents withinPVH, we next tested whether MTII could act as a func-
tional antagonist of the orexigenic actions of NPY within Individual PVH Neurons
Whole-cell recordings were made from mpPVH neuronsthe PVH. MTII (0.3 nmol) was administered first to mice
cannulated unilaterally in the PVH, followed 10 min later that demonstrated a predominant inhibitory synaptic
response to local electrical stimulation, registered as anby administration of 0.14 nmol NPY. While NPY alone
elicited a potent orexigenic response measured at 1 or 2 outward synaptic current (IPSC) when the cell was held
in voltage clamp at 240 mV. The recordings shown herehr (p , 0.001 at 2 hr), pretreatment with MTII completely
suppressed the orexigenic effect of NPY at either time were from the subset of these neurons in which the IPSC
was responsive to NPY, MTII, or a-MSH; in some regionspoint (Figure 2c; p 5 0.48, ACSF±ACSF versus MTII±
NPY). of the PVH, this subset constituted 80% of neurons
Integration of NPY and Melanocortin Signals
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exhibiting an IPSC. These synaptic responses were me-
diated by GABAA receptors, as they were sensitive to
the GABA antagonists picrotoxin (100 mM) or bicuculline
(10 mM). Relatively little change was seen in synaptic
responses in these cells with application of the gluta-
mate receptor antagonists 6-nitro-7-sulphamoylben-
zo(f)quinoxaline-2,3-dione (NBQX; 1 mM; a gift of Novo
Nordisk) and DL-2-amino-5-phosphonovaleric acid (APV;
50 mM). Bath application of MTII (0.1 to 100 nM) caused
a concentration-dependent increase in the IPSC ampli-
tude (Figures 3a, 3b, 3d, and 3e), to a maximum of 163%
of control amplitude. The mean effect of 10 nM MTII
was increased current amplitude (25.18% 6 4.47%). The
EC50 for the response to MTII was 1.4 nM (Log EC50 5
28.85 6 0.19) (Figure 3b). No change was observed
either in the membrane current response to a voltage
step or in the response to a slow voltage ramp, sug-
gesting that the observed changes were not caused by
alterations in electrode access resistance or postsynap-
tic membrane properties.
In 23 of 24 neurons responsive to MTII, application of
NPY (100 nM) caused an inhibition of the IPSC (28.65% 6
Figure 4. MTII Modulates GABA- but Not Glutamate-Mediated2.57%, p ,.0001) (Figures 3c±3e). In four neurons re-
Evoked Synaptic Currents
sponding to a-MSH, all responded to a 100 nM NPY
(a and b) MTII has no effect in the presence of the GABA blockerapplication with an inhibition of the IPSC of 36.75% 6
bicuculline.
3.84%. The action of NPY also appeared to be presynap- (c) The glutamate blocker kynurenate does not prevent the increase
tic, in that there were no alterations in the postsynaptic in IPSC amplitude caused by MTII.
membrane properties or electrode access resistance (d) Effects of bicuculline and kynurenate alone on the evoked synap-
tic current in this neuron. Data are from a single neuron but areaccompanying the presynaptic inhibition.
representative of multiple recordings (n 5 4).The response to MTII was specific, since it could
be blocked in neurons by the MC3/MC4 antagonist
SHU9119 (Figure 3e). In ten neurons, 100 nM MTII an action of MC3/MC4 receptors to enhance GABA re-
caused an increase in the amplitude of the IPSC of lease onto the neurons by a presynaptic mechanism.
24.0% 6 3.66% (p , 0.001). Subsequent application
of SHU9119 (100 nM) caused no effect by itself but Discussion
completely prevented the potentiation of the synaptic
response by cotreatment with 100 nM MTII (0.15 6
The confocal microscopic analysis presented here
0.02%, p , 0.0001). Application of SHU9119 had no
clearly demonstrates neuronal fibers containing both
significant effect on the IPSC inhibition mediated by
NPY and AGRP and neuronal fibers containing a-MSHcotreatment with 300 nM NPY (n 5 5, p . 0.1) (Fig-
adjacent to single-cell bodies within the mpPVH, as wellure 3e).
as the presence of MC4-R IR within the same regionThe natural melanocortin receptor agonist a-MSH
(Figure 1). These data provide evidence of the neuroana-also caused the same effect as MTII. a-MSH caused an
tomical substrate necessary for the cellular integrationincrease in the IPSC of 20% 6 1.16% (10 nM, n 5 3),
of opposing physiological inputs to energy homeostasis.31.8% 6 9.88% (30 nM, n 5 5), and 23.0% 6 4.84%
Inhibition of NPY-induced feeding by intra-PVH ad-(100 nM, n 5 6), again without a change in postsynaptic
ministration of MTII shows that information from POMCproperties, indicating that MTII mimics the action of the
and NPY/AGRP neurons can be functionally integratednatural transmitter (Figure 3e). The actions of a-MSH
within the PVH (Figure 2c). Furthermore, intra-PVH ad-could be prevented by pretreatment with AGRP (10 nM,
ministration of MTII increased oxygen consumption (Fig-n 5 5, p , 0.001) (Figure 3e). Cyclic AMP (cAMP) may
ure 2d), arguing that melanocortin-responsive neuronsbe one second messenger in this system, since the mem-
in the PVH ultimately send outflow affecting the regula-brane-permeable cAMP analog 8(4-chlorophenylthio)-
tion of energy expenditure, as well as energy intake.cAMP increased the amplitude of the evoked GABA
Microinjection of NPY into the PVH has opposing actionscurrent by 38.3% 6 16.4% (p , 0.038) in 6 of 7 MTII-
to those shown here for the melanocortins, stimulatingresponsive neurons tested (Figure 3f).
feeding (Stanley, 1993) but also decreasing energy ex-Application of MTII (100 nM) to mpPVH neurons in the
penditure (Billington et al., 1991; Egawa et al., 1991).presence of the GABAA receptor antagonist bicuculline
While the studies reported here focus on the PVH ashad no effect on the remaining glutamate-mediated syn-
a model system, the data do not exclude the possibilityaptic response (Figures 4a and 4b), but application of
that the adipostat may actually be composed of a dis-MTII to the same neurons in the presence of the gluta-
tributed set of nuclei. Furthermore, the focus here onmate receptor antagonist kynurenate (1 mM) resulted
the POMC and NPY/AGRP fibers in no way rules outin an enhancement of the GABAA-mediated response
critical roles for other orexigenic and anorexigenic neu-(Figures 4c and 4d). Similar results were observed with
NPY (data not shown). These results are consistent with ropeptides within the PVH. The PVH is a site to which
Neuron
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Figure 5. Model for the Integration of a-MSH, NPY, and AGRP Signals at GABAergic Neurons Upstream of the Adipostat
(Top left) Arcuate POMC neurons, arcuate NPY/AGRP neurons, and NPY neurons from other sites such as the brainstem project to GABAergic
interneurons in the mpPVH. These neurons provide inhibitory input to the adipostat neurons. Other inputs (urocortin, CRH, galanin, GLP-1,
neurotensin) and brainstem NPY neurons may also send projections to the PVH GABA interneurons or directly to the PVH adipostat neurons.
(Inset) Melanocortin receptors and NPY receptors in the GABA interneurons may regulate GABA release directly via their opposing action on
adenylyl cyclase. Additional signaling pathways for influencing GABA release include Ca21 channels. Melanocortin and NPY receptors may
be expressed on different populations of GABA interneurons, such that GABA release from multiple GABAergic neurons provides integrated
regulation of the adipostat neurons.
many neurons containing such peptides send dense which the antagonist can stimulate feeding (Figure 2);
however, in the preparations used here, we have notprojections; for example, administration of galanin within
the PVH stimulates feeding, while corticotropin-releas- yet examined the integrity of POMC projections from
the arcuate nucleus.ing hormone (CRH) has potent inhibitory effects (for
review, see Woods et al., 1998). It will be important in Furthermore, in nearly all neurons responding to MC4
receptor agonists, NPY suppressed the IPSC, again byfuture studies to determine if the a-MSH/NPY-sensitive
pathway identified here is also capable of integrating an apparently presynaptic action. Only the GABAA-medi-
ated component of the synaptic response was sensitiveinformation derived from these signals.
The electrophysiological results indicate a common to the actions of melanocortins and NPY, since they
were without effect when the GABAA receptors weresite of opposing action for MC4 and/or MC3 and NPY
receptors at the inhibitory synaptic inputs to a subset blocked (Figure 4). We did not define the NPY receptor
subtype(s) mediating this effect here, but preliminaryof mpPVH neurons. Both MTII and the natural agonist
a-MSH caused a significant potentiation of GABA-medi- data suggest the involvement of multiple NPY receptors
(N. Pronchuk and W. F. Colmers, 1998, Soc. Neurosci.,ated inhibitory postsynaptic responses in these neu-
rons, apparently by a presynaptic action. The action of abstract). Corelease of NPY and AGRP would be ex-
pected to have complementary actions at inhibitory syn-these agonists was blocked both by the selective MC3-
R/MC4-R antagonist SHU9119 as well as by the naturally apses onto a population of parvocellular neurons in the
PVH, simultaneously inhibiting GABA input and pre-occurring MC3-R/MC4-R antagonist AGRP. The obser-
vation that SHU9119 alone did not affect the synaptic venting the potentiation of inhibition by a-MSH. This
synaptic response thus provides a potential site withinresponse suggests that in these hypothalamic slice
preparations, there is a low level of a-MSH tone. This the PVH for the integration of the countervailing signals
arising from the arcuate nucleus. The complementarystands in contrast to in vivo findings with SHU9119, in
Integration of NPY and Melanocortin Signals
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Experimental Proceduresactions of NPY and AGRP within the same neurons could
also potentially explain the observation that deletion of
Animals and Surgical Proceduresthe NPY gene alone has little effect on normal feeding Male Long-Evans rats (450±507 g; Simson Laboratories) and C57BL/6J
behavior in the mouse (Erickson et al., 1996), since mice (wild-type and ob/1, 30±33 g; Jackson Immunoresearch Labo-
AGRP could compensate for the absence of NPY. ratories) were housed on a 12:12 light:dark cycle, with food (Purina
Mouse Chow) and water ad libitum.The melanocortin receptors are all known to couple
Animals were anesthetized with halothane and placed in a stereo-via Gs to activation of adenylyl cyclase (Cone et al.,
taxic apparatus (Cartesian Research). A sterile guide cannula with1996). While the neural melanocortin receptors MC3-R
obdurator stylet was stereotaxically implanted into one side of the
and MC4-R couple efficiently to activation of adenylyl PVH (21.45±1.50 mm relative to bregma, 0.35±0.45 mm lateral to
cyclase in heterologous cells (Roselli-Rehfuss et al., midline, and 7.8±7.9 mm below the bregma for the rat; 20.67±0.77
mm relative to bregma, 0.38±0.48 mm lateral to midline, and 4.69±1993; Mountjoy et al., 1994), the activation of additional
4.75 mm below the surface of the skull for the mouse); for i.c.v.signaling pathways in neurons remains possible (Konda
injection in the mouse, the cannula was implanted with the coordi-et al., 1994). Conversely, the known NPY receptors have
nates of 0.5 mm posterior to the bregma, 1±1.6 mm lateral to the
been shown to couple to Gi and inhibition of adenylyl midline, and 2 mm below the bregma. The cannula was then fixed
cyclase. These receptors have also been demonstrated in place with dental cement. The animals were housed separately
after surgery for at least 1 week for recovery before experiments.to increase intracellular Ca21 (Herzog et al., 1992), as
The positions of the cannulae were verified at the end of the experi-well as directly inhibit voltage-dependent Ca21 channels
ments by histological analysis; in some animals, the positions of(Colmers and Bleakman, 1994). NPY inhibits Ca21 chan-
the cannulae were tested by dye administration prior to sacrifice.
nels in cultured sympathetic cells (Toth et al., 1993) and Positioning of the cannulae in the more dorsal aspect of the PVH
glutamatergic terminals in hippocampal area CA1 (Qian was found to ensure the integrity of the third ventricle and to prevent
et al., 1997), independent of presynaptic levels of cAMP dye from entering the cerebrospinal fluid.
(Klapstein et al., 1990).
Immunohistochemistry and Confocal MicroscopyBased on the coupling data described above, the sim-
Immunofluoresence histochemistry was performed essentially asplest model for the results presented here would be that
described (Gu and Simerly, 1997). After blocking, sections werearcuate POMC and NPY/AGRP neurons project to GABA
treated with a primary antibody cocktail of 1:2,000 v/v goat anti-
interneurons in the PVH to coordinately regulate GABA NPY (Larsen et al., 1992) and 1:2,000 v/v rabbit anti-AGRP (Phoenix
release (Figure 5). However, additional work will be nec- Pharmaceuticals) or 1:2,000 v/v rabbit anti-a-MSH (a gift from Dr.
essary to determine if POMC and NPY/AGRP neurons Richard Allen). Secondary antibodies were donkey anti-goat conju-
gated to Alexa 594 (Molecular Probes; 1:200) and donkey anti-rabbitdirectly contact GABA interneurons in the PVH or indi-
conjugated to FITC (Jackson Immunoresearch Laboratories; 1:200).rectly modulate GABA release. It has been previously
The MC4-R was labeled with an antibody raised to a 14 amino acidshown that NPY can decrease GABA-induced IPSCs in peptide region homologous in rodent and human MC4-R sequences
the arcuate (Glaum et al., 1997) and suprachiasmatic (a gift from Dr. Jarlath ffrench-Mullen) and visualized using the biotin
nuclei (Obrietan and van den Pol, 1996), suggesting that amplification procedure (Lee et al., 1993). Primary antibody treat-
ment was 1:65,000 rabbit anti-MC4-R for 60 hr at 48C, followed bythe inhibition of GABA release may be a general presyn-
1:5,000 v/v biotinylated goat anti-rabbit (Vector Laboratories) andaptic action of NPY within the hypothalamus. Coexpres-
then 2 ml/ml A/B Elite (Vector Laboratories). After rinsing, the sec-sion of NPY and AGRP, of course, argues strongly for
tions were incubated in 1:200 biotinylated tyramide (DuPont, NEN)
coexpression of melanocortin and NPY receptors on the and 0.005% hydrogen peroxide, followed by 1:200 streptavidin con-
same GABAergic neurons. Further experiments will be jugated to FITC (Amersham Life Science). Brains from mice homozy-
gous for the null mutation of MC4-R (Huszar et al., 1997) and fromnecessary to test hypotheses regarding the signaling
wild-type controls were processed in parallel. Nuclei were stainedmechanisms within the presynaptic terminals by which
with 4 mg/ml bis-benzimide (Molecular Probes). Detailed descrip-NPY and melanocortin receptors regulate GABA release.
tions of immunohistochemical protocols may be found at http://
Interestingly, a role for cAMP in the long-term regula- www.neuron.org/cgi/content/full/24/1/155/DC1.
tion of synaptic strength has been seen in circuits involv- Sections were examined on a Leica TCS confocal microscope.
The number of optical sections collected in each image was calcu-ing GABAergic inputs. In opioid dependence, for exam-
lated to give accurate volumetric rendering of the 30 mm section.ple, the increased efficacy of opioid coupling via m
Three-dimensional reconstructions and collapse of the optical sec-receptors to inhibitory GABA inputs in the periaquaduc-
tions were performed with MetaMorph (Universal Imaging).
tal gray appears to involve regulation of adenylyl cyclase
activity (Ingram et al., 1998). Furthermore, adenylyl cy-
Feeding Assay
clase also appears to be involved in the increase in ACSF (in mM: NaCl, 137.9; KCl, 3.37; CaCl2, 1.5; MgCl2, 1.45;
GABA IPSCs in interneurons of the nucleus accumbens NaH2PO4, 1.45; Na2HPO4, 4.85; and H2O, 7 [pH 7.4]) or drugs as
indicated were infused via a preimplanted cannula over a period ofduring opioid withdrawal (Chieng and Williams, 1998).
60 s with a micrometer head (The L. S. Starrett). The animals wereThe mpPVH region characterized here is capable of de-
then put back in cages containing a premeasured quantity of food,tecting energy excess or deficit via the adipostat hor-
and the food intake was measured at the time intervals indicated.
mone leptin acting directly on arcuate POMC (Cheung MTII was from Dr. Victor Hruby (University of Arizona), SHU9119
et al., 1997) and NPY/AGRP (HaÈ kansson et al., 1996; was a gift from Hoffmann-La Roche, and NPY (human) was from
Mercer et al., 1996) neurons to regulate the level of Sigma.
POMC, NPY, and AGRP gene expression (for review,
Indirect O2 Consumption (VO2) Measurementsee Elmquist et al., 1999). Based on these data, it is
Animals were distributed into two weight-matched groups and al-tempting to speculate that the a-MSH- and NPY-regu-
lowed to adapt to the experimental conditions by being placedlated GABA release described here may be one compo-
in the chambers of an indirect open-circuit calorimeter (Oxymax,
nent of the mechanism by which information about adi- Columbus Instruments) for the experimental time period each day
pose deposits is stored over the long-term in order to for at least 3 days. On the day of the experiment, mice were placed
in the measurement chambers for about 2 hr (10:00±12:00 hr) formaintain energy homeostasis.
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acclimatization and then briefly removed from the calorimeter for Research Council/Pharmaceutical Manufacturers Association of
Canada Health Program (W. F. C.). W. F. C. is a Medical ScientistPVH microinjection of either MTII (0.45 nmol/0.3 ml) or ACSF (0.3
of the Alberta Heritage Foundation for Medical Research. We thankml). The animals were then put back in the measurement chambers,
Drs. J. M. H. ffrench-Mullen, Richard Simerly, Nicholas Ling, Philipand measurements were carried out beginning at around 12:00 hr.
Larsen, and Richard Allen for reagents and advice. We thank LindaThe O2 consumption was recorded every 30 min for 4±5 hr with an
Cordilia for assistance with the illustrations.inlet fresh air flow rate of 0.5 l/min and a sample flow rate of 0.4
l/min. Each chamber was sampled for 50 s, with a resettling time
Received March 18, 1999; revised July 26, 1999.of 150 s.
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